BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW)

CUSIP: 10778Y112

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / *W EXP 02/26/202
Total 13F shares
479,858
Share change
+19,035
Total reported value
$196,742
Price per share
$0.41
Number of holders
4
Value change
+$7,804
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 10778Y112?
CUSIP 10778Y112 identifies BCTXW - BriaCell Therapeutics Corp. - *W EXP 02/26/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW) as of Q3 2024

As of 30 Sep 2024, BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 479,858 shares. The largest 4 holders included ARMISTICE CAPITAL, LLC, Redmond Asset Management, LLC, UBS Group AG, and OSAIC HOLDINGS, INC.. This page lists 4 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.